Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness

19 Oct 2022

Abstract excerpt

The incidence and death toll due to SARS-CoV-2 infection varied time-to-time; and depended on several factors, including severity (viral load), immune status, age, gender, vaccination status, and presence of comorbidities. The RNA genome of SARS-CoV-2 has mutated and produced several variants, which were classified by the SARS-CoV-2 Interagency Group (SIG) into four major categories. The first category; “Variant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36298616
DOI: 10.3390/vaccines10101751

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessPMID 36298616Read ↗

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine EfficacySemantic proximity Read ↗

The Variation of SARS-CoV-2 and Advanced Research on Current VaccinesSemantic proximity Read ↗

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19Semantic proximity Read ↗

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Semantic proximity Read ↗

Vaccine efficacy in mutant SARS-CoV-2 variants.Semantic proximity Read ↗

SARS-CoV-2 variants -- molecular properties, virulence, and epidemiologySemantic proximity Read ↗

COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants.Semantic proximity Read ↗

Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.Semantic proximity Read ↗

SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine DevelopmentSemantic proximity Read ↗

The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.Semantic proximity Read ↗

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccinesSemantic proximity Read ↗

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.